News & Announcements

Congratulations to 4 students in the immunology PhD program who graduated on Sunday, May 11, 2025. They were among 442 students from the Duke University School of Medicine who graduated, marking the successful culmination of their hard work and dedication.

Jennifer Brogdon, PhD, Head of Cell and Gene Therapies in the Immuno-Oncology and Hematology Department at Novartis Institutes for Biomedical Research, will speak at Duke on Tuesday, April 22, for the Immunology Seminar Series.

Congratulations to Sejiro Littleton, PhD, who on April 1, 2025, successfully defended his dissertation, "The Cornea Harbors a Tricell

 Jeff Reitano, a PhD student in the lab of Jorn Coers, PhD, has received the National Institute of Allergy and Infectious Disease

Congratulations to Estefany Y. Reyes, PhD, who on March 25, 2025, successfully defended her dissertation, “Host cell responses in the brain during cryptococcal meningoencephalitis.” After graduation she will remain in the lab of Mari L. Shinohara, PhD, professor of integrative immunobiology, to follow up on some exciting projects that emerged from her graduate student research, she said. Long term, she aims to lead an independent research group investigating immune mechanisms in the brain that influence immune responses to infectious agents and autoimmunity.

This prestigious honor recognizes scientific achievement and humanitarian service.

Congratulations to Bryan Jian Wei Lim, PhD, who on March 17, 2025, successfully defended his dissertation, “Heterogeneity of Tumor-Infiltrating CD8+ T Cells: Implications for Systemic Immunity and

Micah Luftig, PhD; Daniel Saban, PhD, MS; and Stephanie Sarantopoulus, MD, PhD, were among 17 faculty members at Duke University School of Medicine awarded distinguished professorships this spring.

We gathered over coffee and pastries to celebrate Women’s History Month.

The National Institutes of Health's proposal to cap reimbursement of facilities and administrative (F&A) costs on research grants at 15% would significantly slow or cease scientific and biomedical research at Duke and other research institutions. Here is an explanation of what F&A costs are and why they are such a critical piece of the research endeavor.